GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alteogen Inc (XKRX:196170) » Definitions » ROE % Adjusted to Book Value

Alteogen (XKRX:196170) ROE % Adjusted to Book Value : 1.57% (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Alteogen ROE % Adjusted to Book Value?

Alteogen's ROE % for the quarter that ended in Dec. 2024 was 94.91%. Alteogen's PB Ratio for the quarter that ended in Dec. 2024 was 60.29. Alteogen's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 1.57%.


Alteogen ROE % Adjusted to Book Value Historical Data

The historical data trend for Alteogen's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alteogen ROE % Adjusted to Book Value Chart

Alteogen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.29 -0.27 -0.43 -0.06 0.49

Alteogen Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.86 0.86 -0.08 -0.21 1.57

Competitive Comparison of Alteogen's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Alteogen's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alteogen's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alteogen's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Alteogen's ROE % Adjusted to Book Value falls into.


;
;

Alteogen ROE % Adjusted to Book Value Calculation

Alteogen's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=29.52% / 60.29
=0.49%

Alteogen's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=94.91% / 60.29
=1.57%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alteogen ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Alteogen's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Alteogen Business Description

Industry
Traded in Other Exchanges
N/A
Address
62, Yuseong-daero 1628beon-gil, Yuseong-gu, Daejeon, KOR, 34054
Alteogen Inc Inc is engaged in the development and manufacture of next-generation biopharmaceuticals using NexP Fusion Technology. It also develops & markets biobetters and biosimilars by partnerships with pharmaceutical companies. It focuses on the areas such as biobetters, a proprietary antibody-drug conjugate, and antibody biosimilars with complexity.

Alteogen Headlines

No Headlines